In High-Risk Patients, MRI Detects Breast Cancers That Mammograms Miss

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Findings published today in the Journal of the American Medical Association suggest that for some women, the best tool for finding breast cancer early may not be a mammogram. The study results indicate that women who have mutations in the so-called breast cancer susceptibility genes (BRCA1 and BRCA2) may be better off getting MRIs.

Having a mutation in either or both BRCA1 and BRCA2 raises a woman's lifetime risk of developing breast cancer significantly. As a result, patients who know they are carrying the genetic mutation are urged to undergo preventive testing every six months. Ellen Warner of the Toronto-Sunnybrook Regional Cancer Center and her colleagues compared four techniques--MRI, mammography, ultrasound and clinical breast exams--utilized by a group of 236 women identified as having breast cancer gene mutations. For six years, the patients received between one and three screenings annually using all of the methods. The team determined that MRIs were the most successful at catching the cancers that developed in the group, doing so 77 percent of the time. In comparison, 36 percent of the cases were detected by mammography and 33 percent by ultrasound.

¿Our results support the position that MRI-based screening is likely to become the cornerstone of breast cancer surveillance for BRCA1 and BRCA2 mutation carriers,¿ the authors write, ¿but it is necessary to demonstrate that this surveillance tool lowers breast cancer mortality before it can be recommended for general use.¿ In an accompanying commentary, Mark E. Robson and Kenneth Offit of New York's Memorial Sloan-Kettering Cancer Center support the proposal that women with a genetic predisposition to breast cancer should be offered MRI screening. They caution, however, that factors such as equipment level, different imaging protocols and radiologist experience could result in MRI screenings that are less effective than those described in the study.

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe